Post-approval studies (Phase 4)Study completedNCT02002221
What this trial is testing
Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients
Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 156